#4 - Surgery Partners (NASDAQ:SGRY)
Surgery Partners Inc. (NASDAQ: SGRY) is a leader in mobile healthcare. The company operates a network of surgical facilities that offer non-emergency procedures and provides surgical centers that handle other procedures lik diagnostic imaging, obstetrics, oncology, and urgent care.
SGRY dropped over 35% in 2024, but analysts are shrugging that off, giving the stock a Moderate Buy rating with up to 87% upside. One reason for the optimism is that after the sell-off, SGRY stock is trading at an attractive valuation due to the company’s leadership in a sector that’s going through significant consolidation.
However, that consolidation means that there will be fewer names, while the total addressable market for these companies is growing. It was about $90 billion at the start of 2024 but is expected to grow by another $60 billion in the coming years.
About Surgery Partners
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Read More - Current Price
- $20.08
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 7 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $36.56 (82.0% Upside)
